SIC 8071 – Medical Laboratories
Valuation | |
---|---|
Market Cap ($M) | 11,130.29 |
Enterprise Value ($M) | 12,889.18 |
Book Value ($M) | 3,145.30 |
Book Value / Share | 17.11 |
Price / Book | 3.54 |
NCAV ($M) | -2,131.66 |
NCAV / Share | -11.59 |
Price / NCAV | -5.22 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.04 |
Return on Assets (ROA) | -0.03 |
Return on Equity (ROE) | -0.07 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.07 |
Current Ratio | 2.32 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 1,194.37 |
Assets | 6,471.33 |
Liabilities | 3,326.03 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 2,499.77 |
Operating Income | -214.39 |
Net Income | -204.15 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 156.12 |
Cash from Investing | 49.68 |
Cash from Financing | 159.77 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | 9.71 | 1.78 | |
13G/A | Wellington Management Group Llp | 5.83 | 1.27 | |
13G/A | BlackRock Inc. | 6.10 | -2.21 | |
13G/A | Jpmorgan Chase & Co | 9.50 | -7.02 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
240,596 | 1,432,779 | 16.79 | |
285,868 | 511,223 | 55.92 | |
407,905 | 740,248 | 55.10 | |
362,264 | 845,568 | 42.84 | |
310,054 | 832,462 | 37.25 | |
(click for more detail) |
Similar Companies | |
---|---|
BGLC – BioNexus Gene Lab Corp. | CELC – Celcuity Inc. |
DMTK – DermTech, Inc. | MDXH – MDxHealth SA |
OPGN – OpGen, Inc. |
Financial data and stock pages provided by
Fintel.io